Compare Annaly Capital Management, Inc. (NLY) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Annaly Capital Management, Inc. vs TransMedics Group Inc — how do they compare? Annaly Capital Management, Inc. trades at $22.9 (market cap $16.63B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Annaly Capital Management, Inc. is far larger — about 6.5× TransMedics Group Inc's market cap, and Annaly Capital Management, Inc. pays a 13.22% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NLY | TMDX | |
|---|---|---|
Market Cap | $16.63B | $2.54B |
Sector | Financials | Technology |
52-Week High | $24.40 | $150.42 |
52-Week Low | $19.96 | $61.99 |
Dividend Yield | 13.22% | — |
Enterprise Value | — | $2.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Annaly Capital Management, Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
